105 related articles for article (PubMed ID: 17176635)
1. Chronic sucrose intake reduces the antagonist effect of beta-funaltrexamine on morphine-induced antinociception in female but not in male rats.
Coy RT; Kanarek RB
Nutr Neurosci; 2006; 9(3-4):131-9. PubMed ID: 17176635
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone antagonism of morphine antinociception in sucrose- and chow-fed rats.
D'Anci KE; Kanarek RB
Nutr Neurosci; 2004 Feb; 7(1):57-61. PubMed ID: 15085560
[TBL] [Abstract][Full Text] [Related]
3. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
[TBL] [Abstract][Full Text] [Related]
4. Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats.
Kanarek RB; Homoleski BA; Wiatr C
Pharmacol Biochem Behav; 2000 Jan; 65(1):97-104. PubMed ID: 10638642
[TBL] [Abstract][Full Text] [Related]
5. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats.
Kanarek RB; Mandillo S; Wiatr C
Brain Res; 2001 Nov; 920(1-2):97-105. PubMed ID: 11716815
[TBL] [Abstract][Full Text] [Related]
6. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
Adams JU; Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
[TBL] [Abstract][Full Text] [Related]
7. Modulation of morphine-induced antinociception by palatable solutions in male and female rats.
Kanarek RB; Homoleski B
Pharmacol Biochem Behav; 2000 Jul; 66(3):653-9. PubMed ID: 10899384
[TBL] [Abstract][Full Text] [Related]
8. Chronic sucrose intake enhances nicotine-induced antinociception in female but not male Long-Evans rats.
Mandillo S; Kanarek RB
Pharmacol Biochem Behav; 2001 Feb; 68(2):211-9. PubMed ID: 11267625
[TBL] [Abstract][Full Text] [Related]
9. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
Mjanger E; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to morphine-induced antinociception is decreased by chronic sucrose or polycose intake.
D'Anci KE
Pharmacol Biochem Behav; 1999 May; 63(1):1-11. PubMed ID: 10340517
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
[TBL] [Abstract][Full Text] [Related]
13. Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats.
Kanarek RB; Mathes WF; Heisler LK; Lima RP; Monfared LS
Pharmacol Biochem Behav; 1997; 57(1-2):377-81. PubMed ID: 9164597
[TBL] [Abstract][Full Text] [Related]
14. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
15. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
[TBL] [Abstract][Full Text] [Related]
16. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
Barrett AC; Smith ES; Picker MJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
[TBL] [Abstract][Full Text] [Related]
17. Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine.
Negus SS; Brandt MR; Gatch MB; Mello NK
Drug Alcohol Depend; 2003 May; 70(1):17-27. PubMed ID: 12681522
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.
Kelley AE; Bless EP; Swanson CJ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1499-507. PubMed ID: 8819538
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone and beta-funaltrexamine antagonism of the antinociceptive and response rate-decreasing effects of morphine, dezocine, and d-propoxyphene.
Walker EA; Tiano MJ; Benyas SI; Dykstra LA; Picker MJ
Psychopharmacology (Berl); 1999 May; 144(1):45-53. PubMed ID: 10379623
[TBL] [Abstract][Full Text] [Related]
20. Dissociable effects of ultralow-dose naltrexone on tolerance to the antinociceptive and cataleptic effects of morphine.
Tuerke KJ; Beninger RJ; Paquette JJ; Olmstead MC
Behav Pharmacol; 2011 Sep; 22(5-6):558-63. PubMed ID: 21555938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
